The Australian Red Cross Blood Service will use the Alinity s System to process its blood tests and improve lab automation.
ProciseDx anticipates bringing rapid, quantitative point-of-care tests to market in 2020 using Lumiphore's metal luminescent reporter technology.
The firms said that their respective technologies are complementary and bridge a technical gap between pathology, radiology, and oncology.
The firms said that Bio-Techne's Ella platform provides the sensitivity needed to provide analysis of the Nf-L biomarker for neurodegenerative diseases.
The agreement covers the manufacture and supply of superparamagnetic particles. T2 Bio will be a non-exclusive reseller of the particles as part of its products.
Abbott said that the Japanese Red Cross Society selected it as the exclusive supplier of blood and plasma screening serological instrumentation, tests, and consumables.
As part of the deal, which is worth at least $3 million for the first five years, Primerdesign will develop and supply 384-well plate molecular assay panels for Genesis.
Under the five-year agreement extension, Quest will continue to provide broad access to Clinical Genomics's InSure One fecal immunochemical test in the US.
Expedeon's colloidal gold is an aqueous suspension of uniform, spherical metallic nanoparticles that can conjugate to antibodies and antigens.
The probes are for use in Cancer Genetics' FISH-based HPV-Associated Cancer Test, which measures genomic changes to help triage cervical cancer patients.